OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

More

Descriptions:

The All-In Podcast — with hosts Jason Calacanis, David Sacks, David Frieberg, and Chamath Palihapitiya — digs into a turbulent week for OpenAI. A Wall Street Journal investigation revealed that OpenAI missed its internal target of reaching one billion weekly active ChatGPT users before the end of 2025 and still hasn’t hit that milestone four months into 2026. The company also reportedly missed its 2025 revenue targets for ChatGPT, raising questions about whether it can service approximately $600 billion in compute spending commitments — a figure the hosts note is roughly equal to OpenAI’s current secondary-market valuation.

Internally, CFO Sarah Frier and CEO Sam Altman are reportedly in tension over the IPO timeline, with Frier skeptical that OpenAI is ready for public reporting standards while Altman is pushing to move faster. The hosts debate whether these are material headwinds or managed expectations from the market leader in a rapidly evolving space. The episode also covers the ongoing Elon Musk vs. Sam Altman lawsuit, with discussion of newly surfaced discovery documents.

The latter half of the episode turns to the competitive AI coding landscape — specifically comparing OpenAI Codex and Anthropic Claude — and covers strong earnings from major hyperscalers, which the hosts interpret as evidence that enterprise AI infrastructure spending remains robust despite broader macroeconomic uncertainty.


📺 Source: All-In Podcast · Published May 01, 2026
🏷️ Format: Podcast

1 Item

Channels

6 Items

Companies

2 Items

People